| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |